Alnylam Pharmaceuticals Inc (ALNY) Business News Aug. 30, 2025, 18:42 UTC Alnylam promuoverà Zilebesiran in un trial clinico globale di fase 3 basato sui risultati cardiovascolari Full text
There are no comments here yet...